class=”sc-29f61514-0 icZBHN”>
Pharmaceutical companies transferred approximately 7.5 million francs directly to doctors in 2022; This is one million more than the previous year. In this way, Pharma finances doctors’ conference fees and pays them for lectures and consultancy activities. There are five professors at the top, and together they raised 279,000 francs.
The highest amount was received by osteoporosis specialist Jean-Yves Reginster, who lives in Lake Geneva. The osteoporosis expert is, among other things, an associate professor at the University of Liège (Belgium) and director of the WHO Collaborating Center on Public Health Aspects of Musculoskeletal Health and Aging.
75,000 francs from a single company
Reginster has published hundreds of publications on various aspects of osteoporosis, osteoarthritis, and frailty. He is also President of the European Osteoporosis and Osteoarthritis Association and co-founder and board member of the International Osteoporosis Foundation.
Reginster received 75,240 francs last year, paid by a single company: Mylan Pharma GmbH in Steinhausen ZG, part of the international Viatris group. Mylan is active in the market with drugs in the field of osteoporosis, among other things.
This article was first published in the paid offer of beobachter.ch. Blick+ users have exclusive access as part of their subscription. You can find more exciting articles at www.beobachter.ch.
This article was first published in the paid offer of beobachter.ch. Blick+ users have exclusive access as part of their subscription. You can find more exciting articles at www.beobachter.ch.
A renowned academic community
In second place is Luc Biedermann (55,677 francs), senior doctor at the Clinic for Gastroenterology and Hepatology (diagnosis and treatment of diseases of the gastrointestinal tract) at the University Hospital Zurich. This is followed by Biedermann’s clinical director, Gerhard Rogler (53,309 francs), who also heads the obesity center at the university hospital. The fourth largest sum went to Alfredo Addeo, head of oncology at the University Hospital of Geneva (53,237 francs), followed by Roger Lehmann, deputy director of the Clinic for Endocrinology, Diabetology and Clinical Nutrition at the University Hospital Zurich (41,326 francs).
The Observer wanted to know to what extent the consultancy work of all five doctors for the pharmaceutical industry and the resulting financial income affected their medical independence. Reginster, Biedermann and Addeo left a request unanswered.
“It definitely suits my education and position.”
Roger Lehmann, who treats patients with diabetes, hormonal disorders and obesity as head of the diabetology department, emphasizes: “I am medically independent, as I teach almost all pharmaceutical companies operating in the diabetes sector. “I usually give these lessons in my spare time and prepare them at home.” According to Lehmann, he is paid between 100 and 150 francs per hour; which is “absolutely appropriate for my education and position.”
Clinic director Gerhard Rogler says about himself that he is considered very “pharmacritic”. “In my view, counseling activities will not affect his medical independence.” He is aware of “potential and actual conflicts of interest.” That’s why I’m making them public and transparent, so I can check at any time whether they’re affecting my prescribing practice.”
Source :Blick
I’m Tim David and I work as an author for 24 Instant News, covering the Market section. With a Bachelor’s Degree in Journalism, my mission is to provide accurate, timely and insightful news coverage that helps our readers stay informed about the latest trends in the market. My writing style is focused on making complex economic topics easy to understand for everyone.
